This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

GZS Announces Worldwide Release Of Hemaglobal™ EHR Patient Registry Solution For Hemophilia And Bleeding Disorders

SAN FRANCISCO, April 2, 2013 /PRNewswire/ -- GZS, Inc., a leader in developing disease-specific and condition-specific Electronic Medical Records/Electronic Health Records (EMR/EHR) and patient registry software solutions, has announced the worldwide release of the WebTracker-Hemophilia EHR patient registry solution used under the new brand name HemaGlobal .

(Logo: http://photos.prnewswire.com/prnh/20130402/LA86901LOGO)

With the release of HemaGlobal, outcomes studies can be conducted on a global scale for the first time.  The EMR/EHR patient registry system is used by virtually all Hemophilia Treatment Centers (HTC) in the U.S. to treat patients with bleeding and clotting disorders and to report high quality de-identified patient data to the Centers for Disease Control and Prevention (CDC).

HemaGlobal is a full-purpose EMR/EHR patient registry system that serves as a stable, scalable platform for integrating data from multiple sources, such as from pharmacies, laboratories, clinics and record archives, and in industry standard formats, including popular front-office applications and mainframe applications with HL-7 interface connectivity. 

HemaGlobal is an ultra-secure web-based solution that can be used on the worldwide web or private intranets, and is intended for government agencies, ministries of health, non-government organizations, universities, treatment centers and healthcare providers throughout the world.

"After years of working closely with physicians and universities to develop a robust EHR patient registry solution for bleeding disorders here in the U.S., we are pleased and excited to extend our success to the rest of the world and truly globalize our understanding of this condition," said Dan Davis, Chief Executive Officer of GZS, Inc.  "We are fortunate that we have found industry to be supportive of efforts to upgrade and standardize on global EHR patient registry applications."

The U.S. consortium of Hemophilia Treatment Centers use the EHR patient registry system as the national information infrastructure for creating and submitting surveillance reports for the CDC's Universal Data Collection (UDC), the Hemophilia Data Set to Maternal and Child Health (MCHB), Healthy People 2020 outcomes and adverse-event reports to the U.S. Food and Drug Administration (FDA).

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs